• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Active Biotech AB

+ Add to Watchlist


18.8000 SEK 1.8000 10.59%

As of 11:30:00 ET on 12/19/2014.

Snapshot for Active Biotech AB (ACTI)

Open: 17.6000 Day's Range: 17.3000 - 19.2000 Volume: 498,853
Previous Close: 17.0000 52wk Range: 15.5000 - 73.3923 1-Yr Rtn: -71.24%

Stock Chart for ACTI

No chart data available.
  • ACTI:SS 18.8000
  • 1D
  • 1M
  • 1Y
Interactive ACTI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACTI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -3.2378
Est. EPS (SEK) (12/2014) -2.7980
Est. PEG Ratio -
Market Cap (M SEK) 1,690.28
Shares Outstanding (M) 89.91
30 Day Average Volume 153,167
Price/Book (mrq) 6.3015
Price/Sale (ttm) 130.8952
Dividend Indicated Gross Yield -%
Cash Dividend (SEK) -
Dividend Ex-Date 02/15/2001
5 Year Dividend Growth -
Next Earnings Announcement 02/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACTI

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for ACTI

Active Biotech AB is a biotechnology company. The Company focuses on research and development of pharmaceuticals and vaccines. Active Biotech does research based on knowledge of the autoimmune/inflammatory diseases and cancer. The Company is developing products designed to treat a variety of diseases including multiple sclerosis, lung, renal, and pancreatic cancer.

Mats ArnhogNon-Executive ChairmanTomas LeandersonPresident/CEO
Hans KolamChief Financial OfficerHelen TuvessonChief Scientific Officer
More Company Profile & Key Executives for ACTI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil